Transplantation of conjunctival epithelial cells cultivated ex vivo in patients with total limbal stem cell deficiency

Cornea
José Reinaldo S RicardoJosé A P Gomes

Abstract

To report the outcomes of transplantation of autologous conjunctival epithelial cells cultivated ex vivo (EVCAU) in patients with total limbal stem cell deficiency (LSCD). EVCAU were cultivated on denuded human amniotic membrane and transplanted in 12 eyes of 10 patients with total LSCD. We evaluated the improvement in the defined clinical parameters of LSCD (loss of corneal epithelial transparency, superficial corneal neovascularization and epithelial irregularity/recurrent epithelial breakdown), vision acuity, impression cytology, immunocytochemical analysis (CK3/CK19), and the appearance of a regular hexagonal basal layer of cells on corneal confocal microscopy. Histologic and immunohistochemical features were studied in 3 corneal buttons of patients submitted to penetrating keratoplasty after EVCAU. Cultivated conjunctival epithelium formed 4 to 5 layers with the formation of basement membrane-like structures. Immunocytochemical analysis showed positivity for CK3, CK19, MUC5AC, Ki-67, P63, and ABCG2. The improvement of the clinical parameters for this treatment in our cohort was 10 of 12 (83.3%) in a mean follow-up time of 18.5 months (range, 15-26 months), and these eyes showed an improvement in impression cytology, immuno...Continue Reading

References

May 1, 1989·Ophthalmology·K R Kenyon, S C Tseng
Feb 15, 2000·Japanese Journal of Ophthalmology·K Tsubota
Jun 22, 2002·Experimental Eye Research·Daniel MellerScheffer C G Tseng
Jun 15, 2007·Current Opinion in Ophthalmology·Jasmeet S DhaliwalAuguste Gy Chiou

❮ Previous
Next ❯

Citations

Aug 27, 2014·Stem Cell Research & Therapy·Kamesh DhamodaranDebashish Das
Feb 20, 2013·Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie·Johannes Menzel-SeveringUrsula Schlötzer-Schrehardt
Jan 21, 2016·Stem Cells International·Michel HaagdorensNadia Zakaria
Nov 3, 2015·Journal français d'ophtalmologie·Y BenayounJ-L Salomon
Sep 22, 2015·Optometry and Vision Science : Official Publication of the American Academy of Optometry·Samantha Bobba, Nick Di Girolamo
Oct 10, 2015·BioMed Research International·Beatriz E RamírezMargarita Calonge
May 30, 2015·Regenerative Medicine·Songtao Yuan, Guoping Fan
Nov 6, 2014·Regenerative Medicine·Ella BuzhorRonit Shtrichman
Aug 9, 2016·Regenerative Medicine·Matthias FuestJodhbir S Mehta
Sep 22, 2016·The Ocular Surface·Alireza Baradaran-RafiiAli R Djalilian
Sep 11, 2014·Stem Cells Translational Medicine·Charanya RamachandranDorairajan Balasubramanian
Jun 13, 2017·International Journal of Molecular Sciences·Anne BukowieckiSabine A Eming
Feb 24, 2018·Expert Opinion on Biological Therapy·Yuzuru SasamotoNatasha Y Frank
May 8, 2019·Journal of Tissue Engineering and Regenerative Medicine·Eun ChoSeung-Yup Ku
Jan 25, 2018·AJR. American Journal of Roentgenology·Stacy K Y FanMehran Midia
Feb 20, 2016·Angewandte Chemie·Falguni PatiHelene Andersson Svahn
Jun 26, 2013·Expert Reviews in Molecular Medicine·Romesh I AngunawelaJulie T Daniels
Feb 17, 2017·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·M FuestJ S Mehta
Jul 9, 2020·Cornea·Sophie X DengUNKNOWN and the International Limbal Stem Cell Deficiency Working Group
May 18, 2018·Frontiers in Bioengineering and Biotechnology·Mona K Marei, Rania M El Backly
Mar 25, 2017·Current Eye Research·Barbara ZsebikLili Takács
Nov 14, 2020·Biopreservation and Biobanking·Arianne J H van VelthovenStefano Ferrari
Nov 27, 2020·Translational Vision Science & Technology·Ricardo M Gouveia, Che J Connon
Feb 3, 2021·International Journal of Molecular Sciences·Louis-Philippe GuérinSylvain L Guérin
Nov 12, 2014·European Journal of Ophthalmology·Paulo C SilberJosé A P Gomes
Aug 29, 2021·Pharmaceutics·Yolanda Diebold, Laura García-Posadas
Sep 7, 2021·Frontiers in Medicine·Ayyad Zartasht KhanJon Roger Eidet

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.